The MRNA Quarterly Volume chart reveals an overall increasing trend in trading activity from Q1 2023 to Q4 2024, despite some quarterly fluctuations. Volumes in 2023 showed a steady rise, culminating in a strong Q4 with approximately 300 million units traded.

Activity in 2024 generally remained elevated compared to early 2023, experiencing a remarkable surge in Q4 2024. During this quarter, volume peaked at nearly 480 million units, marking the highest point in the observed period and indicating significantly heightened investor interest.